REQUEST A DEMO
Total
USD $0.00
Search more companies

Bukwang Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Bukwang Pharmaceutical Co.,Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bukwang Pharmaceutical Co., Ltd is a pharmaceutical company. The company's main business includes manufacturing and selling ethical drugs, over-the-counter drugs, nutraceuticals, and personal care products. They are actively involved in open innovation and are developing new immuno-oncology therapeutics and CAR-T treatments. The company has subsidiaries and affiliates, including Dyna Therapeutics and JaguAhR Therapeutics, and is focused on improving anti-cancer medicine.

Headquarters
398-1 Dehbahng-Dong, Dongjahk-Gu
Seoul; Seoul; Postal Code: 156-811

Contact Details: Purchase the Bukwang Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.bukwang.co.kr

Basic Information
Total Employees:
Purchase the Bukwang Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bukwang Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bukwang Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Bukwang Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
October 17, 1960
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
21.52%
Purchase this report to view the information.
3.77%
Purchase this report to view the information.
1.16%
Purchase this report to view the information.
0.99%
Purchase this report to view the information.
0.11%
Subsidiaries
Contera Pharma A/S
다이나 세라퓨틱스(주)
부광메디카(주)
Company Performance
Financial values in the chart are available after Bukwang Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
21.33%
Total operating revenue
19.85%
Operating Profit/Loss (EBIT)
N/A
EBITDA
96.44%
Net Profit/Loss for the Period
N/A
Total Assets
35.6%
Total Equity
48.85%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-11.08%
Quick Ratio
-1.41%
Cash Ratio
-3.68%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?